trimetazidine has been researched along with Diabetes Mellitus, Adult-Onset in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.17) | 18.2507 |
| 2000's | 14 (58.33) | 29.6817 |
| 2010's | 7 (29.17) | 24.3611 |
| 2020's | 2 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Arduini, A; Ceccarelli, SM; Chomienne, O; Gubler, M | 1 |
| Bilovol, O; Dunaieva, I; Kiriienko, O; Knyazkova, I | 1 |
| Li, T; Shao, S; Xu, Q; Yang, Y | 1 |
| Han, X; Jing, Q; Li, R; Tang, X; Wang, Q; Yang, M; Yu, X; Zhao, J | 1 |
| Gaszner, B; Hild, G; Kónyi, A; Meiszterics, Z; Sárszegi, Z | 1 |
| Shehata, M | 1 |
| Amaral, N; Okonko, DO | 1 |
| Fi, Z; Kovács, G; Szentes, V | 1 |
| Belardinelli, R; Cianci, G; Gigli, M; Lacalaprice, F; Mazzanti, M | 1 |
| Cera, M; Fragasso, G; Margonato, A; Montanaro, C; Salerno, A; Spoladore, R | 1 |
| Jammula, S; Kota, SK; Modi, KD; Panda, S | 1 |
| Calori, G; Fragasso, G; Lopaschuk, GD; Margonato, A; Monti, L; Palloshi, A; Piatti Md, PM; Puccetti, P; Setola, E | 1 |
| Atroshenkov, AV; Chernov, VI; Efimova, EV; Karpov, RS; Koshel'skaia, OA; Ocheredko, NA | 1 |
| Malmberg, K; Rydén, L; Thrainsdottir, IS; von Bibra, H | 1 |
| Alcalá López, J; Gil Polo, B; Maicas Bellido, C; Rodríguez Padial, L; Velázquez Martín, M | 1 |
| Gil Polo, B; Maicas Bellido, C; Rodríguez Padial, L; Velázquez Martín, M | 1 |
| Camisasca, RP; Fragasso, G; Galluccio, E; Lucotti, P; Margonato, A; Monti, LD; Origgi, A; Piatti, P; Setola, E | 1 |
| Fini, M; Rosano, GM; Vitale, C; Volterrani, M | 1 |
| Affinito, S; Marzilli, M | 1 |
| Fini, M; Gebara, O; Marazzi, G; Patrizi, R; Pelliccia, F; Pierri, H; Ramires, JA; Rosano, GM; Vitale, C; Volterrani, M; Wajngarten, M | 1 |
| Leitão, C; Polanczyk, CA; Ribeiro, JP; Ribeiro, LW; Stein, R | 1 |
| Marazzi, G; Rosano, GM; Volterrani, M | 1 |
| Makolkin, VI; Mikova, NV; Petriĭ, VV | 1 |
| Pogátsa, G | 1 |
7 review(s) available for trimetazidine and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Metabolic abnormalities of the heart in type II diabetes.
Topics: Antioxidants; Cardiovascular Agents; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Energy Metabolism; Fatty Acids; Glucose; Humans; Mitochondria, Heart; Myocardium; Organophosphorus Compounds; Oxidative Phosphorylation; Oxidative Stress; Perhexiline; Ranolazine; Trimetazidine; Ubiquinone | 2015 |
[Role of trimetazidine in the treatment of diabetic microangiopathy in ischaemic heart disease].
Topics: Angina Pectoris; Anti-Inflammatory Agents, Non-Steroidal; Coronary Artery Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Heart; Humans; Myocardial Infarction; Myocardial Ischemia; Myocardium; Trimetazidine; Vasodilator Agents | 2015 |
Effects of metabolic approach in diabetic patients with coronary artery disease.
Topics: Acetyl-CoA C-Acyltransferase; Carnitine O-Palmitoyltransferase; Coronary Artery Disease; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Glucose; Humans; Trimetazidine; Vasodilator Agents; Ventricular Dysfunction, Left | 2009 |
Effect of diabetes on alteration of metabolism in cardiac myocytes: therapeutic implications.
Topics: Adenosine Triphosphate; Collagen; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Energy Metabolism; Extracellular Matrix Proteins; Fatty Acids, Nonesterified; Female; Glycation End Products, Advanced; Humans; Insulin; Ion Channels; Male; Mitochondria, Heart; Mitochondrial Proteins; Myocytes, Cardiac; Oxygen Consumption; Trimetazidine; Uncoupling Protein 1; Vasodilator Agents; Ventricular Dysfunction | 2011 |
Metabolic therapy for the diabetic patients with ischaemic heart disease.
Topics: Carbohydrate Metabolism; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Humans; Myocardial Ischemia; Myocardium; Trimetazidine; Vasodilator Agents | 2005 |
Meeting the challenge of chronic ischaemic heart disease with trimetazidine.
Topics: Diabetes Complications; Diabetes Mellitus, Type 2; Humans; Myocardial Ischemia; Randomized Controlled Trials as Topic; Trimetazidine; Vasodilator Agents | 2005 |
[New concepts in the therapy of diabetic cardiopathies].
Topics: Adenosine Triphosphate; Cardiomyopathies; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Heart Diseases; Humans; Trimetazidine | 1997 |
10 trial(s) available for trimetazidine and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
The effect of trimetazidine treatment in patients with type 2 diabetes undergoing percutaneous coronary intervention for AMI.
Topics: Adenosine; Aged; Alanine Transaminase; Aspartate Aminotransferases; Aspirin; Blood Glucose; Cardiac Output; China; Creatine Kinase; Creatine Kinase, MB Form; Creatinine; Diabetes Mellitus, Type 2; Echocardiography; Female; Glycated Hemoglobin; Heart Atria; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Stroke Volume; Ticagrelor; Treatment Outcome; Trimetazidine; Troponin I; Urea; Vasodilator Agents | 2017 |
Impact of trimetazidine on incidence of myocardial injury and contrast-induced nephropathy in diabetic patients with renal dysfunction undergoing elective percutaneous coronary intervention.
Topics: Contrast Media; Coronary Angiography; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Elective Surgical Procedures; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Male; Middle Aged; Myocardial Ischemia; Percutaneous Coronary Intervention; Prospective Studies; Renal Insufficiency; Treatment Outcome; Trimetazidine; Vasodilator Agents | 2014 |
Effects of trimetazidine on myocardial perfusion and left ventricular systolic function in type 2 diabetic patients with ischemic cardiomyopathy.
Topics: Cardiomyopathies; Coronary Circulation; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Systole; Trimetazidine; Vasodilator Agents; Ventricular Function, Left | 2008 |
Short- and long-term beneficial effects of trimetazidine in patients with diabetes and ischemic cardiomyopathy.
Topics: Aged; Diabetes Mellitus, Type 2; Double-Blind Method; Echocardiography; Energy Metabolism; Glucose; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardium; Trimetazidine | 2003 |
[Clinical Efficacy of Combination Therapy With Trimetazidine and Angiotensin Converting Enzyme Inhibitors in Patients With Hypertension and Ischemic Heart Disease Associated With Type II Diabetes].
Topics: Angiotensin-Converting Enzyme Inhibitors; Diabetes Mellitus, Type 2; Humans; Hypertension; Myocardial Ischemia; Treatment Outcome; Trimetazidine | 2004 |
Effects of trimetazidine on left ventricular function in patients with type 2 diabetes and heart failure.
Topics: Aged; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Echocardiography; Exercise Test; Female; Heart Failure; Humans; Male; Oxygen Consumption; Trimetazidine; Vasodilator Agents; Ventricular Function, Left | 2004 |
Metabolic and endothelial effects of trimetazidine on forearm skeletal muscle in patients with type 2 diabetes and ischemic cardiomyopathy.
Topics: 3-Hydroxybutyric Acid; Aged; Blood Glucose; Citric Acid; Cross-Over Studies; Cyclic GMP; Diabetes Mellitus, Type 2; Double-Blind Method; Endothelin-1; Endothelium, Vascular; Fatty Acids, Nonesterified; Forearm; Glucose; Glucose Clamp Technique; Humans; Insulin; Insulin Resistance; Lipid Metabolism; Male; Middle Aged; Muscle, Skeletal; Myocardial Ischemia; Oxidation-Reduction; Trimetazidine | 2006 |
Effect of free fatty acid inhibition on silent and symptomatic myocardial ischemia in diabetic patients with coronary artery disease.
Topics: Aged; Coronary Artery Disease; Diabetes Mellitus, Type 2; Double-Blind Method; Electrocardiography, Ambulatory; Fatty Acids, Nonesterified; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Oxidation-Reduction; Trimetazidine; Vasodilator Agents | 2007 |
Trimetazidine added to combined hemodynamic antianginal therapy in patients with type 2 diabetes: a randomized crossover trial.
Topics: Angina Pectoris; Blood Pressure Monitoring, Ambulatory; Cross-Over Studies; Diabetes Mellitus, Type 2; Drug Administration Schedule; Electrocardiography, Ambulatory; Exercise Test; Female; Humans; Male; Middle Aged; Trimetazidine | 2007 |
[Correction of episodes of transitory myocardial ischemia with trimetazidine in patients with ischemic heart disease combined with type 2 diabetes mellitus].
Topics: Diabetes Mellitus, Type 2; Electrocardiography, Ambulatory; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Severity of Illness Index; Treatment Outcome; Trimetazidine; Vasodilator Agents | 2007 |
7 other study(ies) available for trimetazidine and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Carnitine palmitoyltransferase (CPT) modulators: a medicinal chemistry perspective on 35 years of research.
Topics: Animals; Carnitine; Carnitine O-Palmitoyltransferase; Catalytic Domain; Diabetes Mellitus, Type 2; Energy Metabolism; Enzyme Activators; Ethylene Oxide; Heart Failure; Humans; Insulin Resistance; Isoenzymes; Lipid Metabolism; Myocardial Ischemia; Organ Specificity; Protein Conformation; Sequence Homology, Amino Acid; Stereoisomerism | 2011 |
PARAMETERS OF LEFT VENTRICULAR DIASTOLIC DYSFUNCTION IN PATIENTS WITH HYPERTENSION DISEASE WITH CONCOMITANT TYPE 2 DIABETES.
Topics: Diabetes Mellitus, Type 2; Eplerenone; Female; Glycated Hemoglobin; Humans; Hypertension; Male; Middle Aged; Trimetazidine; Ventricular Dysfunction, Left | 2023 |
Trimetazidine ameliorates hindlimb ischaemic damage in type 2 diabetic mice.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Hindlimb; Humans; Intercellular Adhesion Molecule-1; Ischemia; Lower Extremity; Mice; Mice, Inbred C57BL; Muscle, Skeletal; Peripheral Arterial Disease; Trimetazidine; Vascular Endothelial Growth Factor A | 2021 |
Effectiveness and safety of anti-ischemic trimetazidine in patients with stable angina pectoris and Type 2 diabetes.
Topics: Aged; Angina, Stable; Canada; Coronary Artery Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Administration Schedule; Female; Humans; Male; Myocardial Ischemia; Prospective Studies; Pulse Wave Analysis; Trimetazidine; Vasodilator Agents | 2017 |
[Limited application of prevention measures in patients with diabetes mellitus type 2 and coronary artery disease in Spain. DIETRIC study].
Topics: Aged; Coronary Artery Disease; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; Risk Factors; Spain; Trimetazidine; Vasodilator Agents | 2005 |
[A prospective study on trimetazidine effectiveness and tolerability in diabetic patients in association to the previous treatment of their coronary disease. DIETRIC study].
Topics: Adult; Aged; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Humans; Male; Middle Aged; Prospective Studies; Trimetazidine; Vasodilator Agents | 2005 |
Metabolic agents in the management of diabetic coronary patients: a new era.
Topics: Acetanilides; Citric Acid Cycle; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dichloroacetic Acid; Enzyme Inhibitors; Epoxy Compounds; Humans; Insulin Resistance; Perhexiline; Piperazines; Ranolazine; Trimetazidine; Vasodilator Agents | 2008 |